An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
Genetic changes that protected their ancestors against fly-borne parasites may partly explain why African-Americans with lupus are up to five times more likely to develop end-stage kidney disease than those of European descent. This was the conclusion of a study presented this week at the American College of Rheumatology Scientific Sessions in Washington, D.C.